arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Medpace Holdings, Inc.

MEDP
$590.57 ▲ +5.37 (+0.92%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
46 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
89
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Medpace Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $16.6B
Dividend Yield
Revenue Growth 17.2%
Op. Margin 20.8%
ROIC 27.1%
FCF / Share $4.90
Trailing P/E 137.0x
Price / Book 38.0x
FCF Yield 0.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

46-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$707.33M
↑ +17.2%
Net Income Profit after all expenses
$123.87M
↑ +8.1%
Operating Margin Operating profit as % of sales
20.8%
↑ +3.7% 77th
FCF / Share Free cash flow per share
$4.90
↓ -3.8%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
82
Returns
99
Cash Quality
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 46 quarters